Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
75.07 ^USD	-0.99%		-0.85%	+2.16%

May. 15	Bruker Keeps Quarterly Dividend at $0.05 Per Share; Payable June 17 to Shareholders of Record on June 3	MT
May. 15	Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024	CI

Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024

May 02, 2024 at 07:00 am EDT

Bruker Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 721.7 million compared to USD 685.3 million a year ago. Net income was USD 50.9 million compared to USD 76.5 million a year ago.

Basic earnings per share from continuing operations was USD 0.35 compared to USD 0.52 a year ago. Diluted earnings per share from continuing operations was USD 0.35 compared to USD 0.52 a year ago.

Latest news about Bruker Corporation

Bruker Keeps Quarterly Dividend at $0.05 Per Share; Payable June 17 to Shareholders of Record on June 3	May. 15	MT
Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024	May. 15	CI
Bruker's NanoString Secures Patent Case Win in Germany	May. 07	MT
Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.	May. 05	CI
Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance	May. 02	MT
Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M	May. 02	MT
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q1 EPS $0.53, vs. Street Est of $0.46	May. 02	MT
Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Bruker Corporation Revises Earnings Guidance for the Year 2024	May. 02	CI
Bruker Corporation completed the acquisition of ELITech Group SAS from Tecfin S.À R.L.	Apr. 29	CI
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference	Apr. 26	CI
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	Apr. 22	MT
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million.	Apr. 16	CI
Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	Apr. 10	MT
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	Apr. 08	CI
Bruker Corporation Enters into Term Loan Agreement with Bank of America, N.A	Apr. 02	CI
Bruker Corporation Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO	Mar. 11	CI
Bruker Corporation completed the acquisition of Chemspeed Technologies AG.	Mar. 06	CI
Transcript : Bruker Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM	Mar. 04
UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating	Mar. 01	MT
Transcript : Bruker Corporation Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 08:45 AM	Feb. 29
Bruker to Acquire ELITechGroup for About $943 Million in Cash	Feb. 28	MT
Bruker Corporation entered into an agreement to acquire ELITech Group SAS from Tecfin S.À R.L. for approximately ?870 million.	Feb. 27	CI
Bruker Insider Sold Shares Worth $1,276,073, According to a Recent SEC Filing	Feb. 26	MT

Chart Bruker Corporation

Duration

Period

More charts

Company Profile

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Bruker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

75.07 USD

Average target price

85.7 USD

Spread / Average Target

+14.16%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRUKER CORPORATION	+2.16%	11.02B
THERMO FISHER SCIENTIFIC	+12.15%	228B
DANAHER CORPORATION	+14.90%	196B
INTUITIVE SURGICAL, INC.	+18.22%	141B
BOSTON SCIENTIFIC CORPORATION	+29.15%	110B
SIEMENS HEALTHINEERS AG	+0.53%	65.88B
EDWARDS LIFESCIENCES CORPORATION	+16.92%	54.3B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.33%	52.39B
AGILENT TECHNOLOGIES, INC.	+10.93%	45.22B
GE HEALTHCARE TECHNOLOGIES INC.	+5.87%	37.12B

Other Advanced Medical Equipment & Technology